Adalimumab: new indication. Ankylosing spondylitis: just another TNF alpha antagonist. No comparisons with other TNF alpha antagonists.
D018501:Antirheumatic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D005602:France; D006801:Humans; D007279:Injections, Subcutaneous; D016032:Randomized Controlled Trials as Topic; D013167:Spondylitis, Ankylosing / Q000188:drug therapy*; D045162:Thiazolidinediones / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D018501:Antirheumatic Agents; D045162:Thiazolidinediones